MATTHEW OTTINGER: Open Payments
NPI 1174172563 · EAST STROUDSBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$712 in 36 payments from 8 companies in 2025. Trend: 2023 $254 · 2024 $1,133 · 2025 $712
Food & beverage: $571Education: $141
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 16 | $273 |
| E.R. Squibb & Sons, L.L.C. | 9 | $141 |
| Neurocrine BioSciences, Inc. | 2 | $97 |
| Alkermes, Inc. | 2 | $51 |
| Vanda Pharmaceuticals Inc. | 2 | $47 |
| Janssen Pharmaceuticals, Inc | 2 | $44 |
| Lundbeck LLC | 2 | $39 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
Products named: COBENFY, INGREZZA, AUSTEDO XR, UZEDY, VIVITROL, FANAPT, INVEGA SUSTENNA, REXULTI.
Industry payments across PA — which companies pay providers there.
